Table of Content

Executive Summary



Chapter 1 – Introduction



Chapter 2 – Trends in ophthalmics dealmaking



2.1. Introduction

2.2. Ophthalmics partnering over the years

2.3. Ophthalmics partnering by deal type

2.4. Ophthalmics partnering by industry sector

2.5. Ophthalmics partnering by stage of development

2.6. Ophthalmics partnering by technology type

2.7. Ophthalmics partnering by therapeutic indication



Chapter 3 – Financial deal terms for ophthalmics partnering



3.1. Introduction

3.2. Disclosed financials terms for ophthalmics partnering

3.3. Ophthalmics partnering headline values

3.4. Ophthalmics deal upfront payments

3.5. Ophthalmics deal milestone payments

3.6. Ophthalmics royalty rates



Chapter 4 – Leading ophthalmics deals and dealmakers



4.1. Introduction

4.2. Most active in ophthalmics partnering

4.3. List of most active dealmakers in ophthalmics

4.4. Top ophthalmics deals by value



Chapter 5 – Ophthalmics contract document directory



5.1. Introduction

5.2. Ophthalmics partnering deals where contract document available



Chapter 6 – Ophthalmics dealmaking by therapeutic target



6.1. Introduction

6.2. Deals by ophthalmics therapeutic target



Deal directory



Deal directory – Ophthalmics deals by company A-Z 2016 to 2023

Deal directory – Ophthalmics deals by technology type 2016 to 2023



Deal type definitions



About Wildwood Ventures



Current Partnering

Current Agreements

Recent report titles from CurrentPartnering



Table of figures



Figure 1: Ophthalmics partnering since 2016

Figure 2: Ophthalmics partnering by deal type since 2016

Figure 3: Ophthalmics partnering by industry sector since 2016

Figure 4: Ophthalmics partnering by stage of development since 2016

Figure 5: Ophthalmics partnering by technology type since 2016

Figure 6: Ophthalmics partnering by indication since 2016

Figure 7: Ophthalmics deals with a headline value

Figure 8: Ophthalmics deals with upfront payment values

Figure 9: Ophthalmics deals with milestone payment

Figure 10: Ophthalmics deals with royalty rates

Figure 11: Active ophthalmics dealmaking activity since 2016

Figure 12: Top ophthalmics deals by value since 2016